WebThe Company employs more than 300 skilled personnel and has three principal operating divisions: Animal Health, Food Safety, and Human Health, which includes Bioniche Therapeutics and Bioniche Pharma Group. The Companys primary goal is to develop proprietary cancer therapies supported by revenues from marketed products in human … WebBioniche Life Sciences Profile and History . Telesta Therapeutics Inc is a company that operates in the Biotechnology industry. It employs 101-250 people and has $25M-$50M …
Pro-inflammatory activity of contaminating DNA in hyaluronic …
WebNov 26, 2009 · Bioniche Life Sciences Inc. is a research-based, technology-driven Canadian biopharmaceutical company focused on the discovery, development, … WebFeb 14, 2003 · 1 Bioniche Therapeutics Division, Bioniche Life Sciences Inc, Montreal, Que, Canada H4P 2R2. [email protected]; PMID: 12547612 DOI: 10.1016/s0264-410x(02)00549-2 Abstract We have previously reported that DNA isolated from Mycobacterium phlei (M. phlei) stimulates the synthesis of cytokines by monocytes and … properties to buy in rochester
Development of short non-CpG phosphodiester oligonucleotides …
WebNov 24, 2014 · BELLEVILLE, ON, Nov. 24, 2014 /PRNewswire/ - Bioniche Life Sciences Inc. Bioniche Life Sciences today announced the accomplishment of another major milestone in the execution of its strategic... October 4, 2024 WebMar 13, 2006 · Bioniche is in a position to develop effective treatments for cancer using these unique and complementary technology platforms." Graeme McRae, President & CEO of Bioniche Life Sciences Inc., commented, "The oligonucleotide platform is another example of Bioniche's ability to develop novel technologies. ... (Bioniche … WebSupport: 888-992-3836 Home NewsWire Subscriptions ... properties to buy inverness